TY - JOUR
T1 - Disease characteristics of MCT8 deficiency
T2 - an international, retrospective, multicentre cohort study
AU - Groeneweg, Stefan
AU - van Geest, Ferdy S.
AU - Abaci, Ayhan
AU - Alcantud, Alberto
AU - Ambegaonkar, Gautem P.
AU - Armour, Christine M.
AU - Bakhtiani, Priyanka
AU - Barca, Diana
AU - Bertini, Enrico S.
AU - van Beynum, Ingrid M.
AU - Brunetti-Pierri, Nicola
AU - Bugiani, Marianna
AU - Cappa, Marco
AU - Cappuccio, Gerarda
AU - Castellotti, Barbara
AU - Castiglioni, Claudia
AU - Chatterjee, Krishna
AU - de Coo, Irenaeus F. M.
AU - Coutant, Regis
AU - Craiu, Dana
AU - Crock, Patricia
AU - DeGoede, Christian
AU - Demir, Korcan
AU - Dica, Alice
AU - Dimitri, Paul
AU - Dolcetta-Capuzzo, Anna
AU - Dremmen, Marjolein H. G.
AU - Dubey, Rachana
AU - Enderli, Anina
AU - Fairchild, Jan
AU - Gallichan, Jonathan
AU - George, Belinda
AU - Gevers, Evelien F.
AU - Hackenberg, Annette
AU - Halasz, Zita
AU - Heinrich, Bianka
AU - Huynh, Tony
AU - Klosowska, Anna
AU - van der Knaap, Marjo S.
AU - van der Knoop, Marieke M.
AU - Konrad, Daniel
AU - Koolen, David A.
AU - Krude, Heiko
AU - Lawson-Yuen, Amy
AU - Lebl, Jan
AU - Linder-Lucht, Michaela
AU - Lorea, Claudia F.
AU - Lourenco, Charles M.
AU - Lunsing, Roelineke J.
AU - Lyons, Greta
PY - 2020/7
Y1 - 2020/7
N2 - Background Disordered thyroid hormone transport, due to mutations in the SLC16A2 gene encoding monocarboxylate transporter 8 (MCT8), is characterised by intellectual and motor disability resulting from cerebral hypothyroidism and chronic peripheral thyrotoxicosis. We sought to systematically assess the phenotypic characteristics and natural history of patients with MCT8 deficiency. p p p Interpretation Our description of characteristics of MCT8 deficiency in a large patient cohort reveals poor survival with a high prevalence of treatable underlying risk factors, and provides knowledge that might inform clinical management and future evaluation of therapies.
AB - Background Disordered thyroid hormone transport, due to mutations in the SLC16A2 gene encoding monocarboxylate transporter 8 (MCT8), is characterised by intellectual and motor disability resulting from cerebral hypothyroidism and chronic peripheral thyrotoxicosis. We sought to systematically assess the phenotypic characteristics and natural history of patients with MCT8 deficiency. p p p Interpretation Our description of characteristics of MCT8 deficiency in a large patient cohort reveals poor survival with a high prevalence of treatable underlying risk factors, and provides knowledge that might inform clinical management and future evaluation of therapies.
KW - MONOCARBOXYLATE TRANSPORTER-8
KW - PSYCHOMOTOR RETARDATION
KW - HEART-RATE
KW - HORMONE
KW - MUTATIONS
U2 - 10.1016/S2213-8587(20)30153-4
DO - 10.1016/S2213-8587(20)30153-4
M3 - Article
SN - 2213-8587
VL - 8
SP - 594
EP - 605
JO - Lancet Diabetes & Endocrinology
JF - Lancet Diabetes & Endocrinology
IS - 7
ER -